Literature DB >> 34619135

Chronic Exposure to Palmitic Acid Down-Regulates AKT in Beta-Cells through Activation of mTOR.

Richa Aggarwal1, Zhechu Peng1, Ni Zeng1, Joshua Silva1, Lina He1, Jingyu Chen1, Anketse Debebe1, Taojian Tu1, Mario Alba1, Chien-Yu Chen1, Eileen X Stiles1, Handan Hong1, Bangyan L Stiles2.   

Abstract

High circulating lipids occurring in obese individuals and insulin-resistant patients are considered a contributing factor to type 2 diabetes. Exposure to high lipid concentration is proposed to both protect and damage beta-cells under different circumstances. Here, by feeding mice a high-fat diet (HFD) for 2 weeks to up to 14 months, the study showed that HFD initially causes the beta-cells to expand in population, whereas long-term exposure to HFD is associated with failure of beta-cells and the inability of animals to respond to glucose challenge. To prevent the failure of beta-cells and the development of type 2 diabetes, the molecular mechanisms that underlie this biphasic response of beta-cells to lipid exposure were explored. Using palmitic acid (PA) in cultured beta-cells and islets, the study demonstrated that chronic exposure to lipids leads to reduced viability and inhibition of cell cycle progression concurrent with down-regulation of a pro-growth/survival kinase AKT, independent of glucose. This AKT down-regulation by PA is correlated with the induction of mTOR/S6K activity. Inhibiting mTOR activity with rapamycin induced Raptor and restored AKT activity, allowing beta-cells to gain proliferation capacity that was lost after HFD exposure. In summary, a novel mechanism in which lipid exposure may cause the dipole effects on beta-cell growth was elucidated, where mTOR acts as a lipid sensor. These mechanisms can be novel targets for future therapeutic developments.
Copyright © 2022 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34619135      PMCID: PMC8759041          DOI: 10.1016/j.ajpath.2021.09.008

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  79 in total

1.  Control of pancreatic β cell regeneration by glucose metabolism.

Authors:  Shay Porat; Noa Weinberg-Corem; Sharona Tornovsky-Babaey; Rachel Schyr-Ben-Haroush; Ayat Hija; Miri Stolovich-Rain; Daniela Dadon; Zvi Granot; Vered Ben-Hur; Peter White; Christophe A Girard; Rotem Karni; Klaus H Kaestner; Frances M Ashcroft; Mark A Magnuson; Ann Saada; Joseph Grimsby; Benjamin Glaser; Yuval Dor
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

2.  Myc Is Required for Adaptive β-Cell Replication in Young Mice but Is Not Sufficient in One-Year-Old Mice Fed With a High-Fat Diet.

Authors:  Carolina Rosselot; Anil Kumar; Jayalakshmi Lakshmipathi; Pili Zhang; Geming Lu; Liora S Katz; Edward V Prochownik; Andrew F Stewart; Luca Lambertini; Donald K Scott; Adolfo Garcia-Ocaña
Journal:  Diabetes       Date:  2019-07-10       Impact factor: 9.461

3.  Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.

Authors:  Ting Yuan; Sahar Rafizadeh; Kanaka Durga Devi Gorrepati; Blaz Lupse; Jose Oberholzer; Kathrin Maedler; Amin Ardestani
Journal:  Diabetologia       Date:  2016-12-21       Impact factor: 10.122

4.  Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha.

Authors:  R L Tuttle; N S Gill; W Pugh; J P Lee; B Koeberlein; E E Furth; K S Polonsky; A Naji; M J Birnbaum
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

Review 5.  Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets.

Authors:  Guim Kwon; Connie A Marshall; Kirk L Pappan; Maria S Remedi; Michael L McDaniel
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

6.  Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass.

Authors:  Jennifer Roccisana; Vasumathi Reddy; Rupangi C Vasavada; Jose A Gonzalez-Pertusa; Mark A Magnuson; Adolfo Garcia-Ocaña
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

Review 7.  mTOR Signaling in Growth, Metabolism, and Disease.

Authors:  Robert A Saxton; David M Sabatini
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

8.  Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells.

Authors:  Ernesto Bernal-Mizrachi; Szabolcs Fatrai; James D Johnson; Mitsuru Ohsugi; Kenichi Otani; Zhiqiang Han; Kenneth S Polonsky; M Alan Permutt
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

9.  Adult-onset deletion of Pten increases islet mass and beta cell proliferation in mice.

Authors:  Kai-Ting Yang; Jennifer-Ann Bayan; Ni Zeng; Richa Aggarwal; Lina He; Zhechu Peng; Anketse Kassa; Melissa Kim; Zhiou Luo; Zhenrong Shi; Vivian Medina; Keerthi Boddupally; Bangyan L Stiles
Journal:  Diabetologia       Date:  2013-10-26       Impact factor: 10.122

Review 10.  Human β-cell proliferation and intracellular signaling: part 3.

Authors:  Andrew F Stewart; Mehboob A Hussain; Adolfo García-Ocaña; Rupangi C Vasavada; Anil Bhushan; Ernesto Bernal-Mizrachi; Rohit N Kulkarni
Journal:  Diabetes       Date:  2015-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.